Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection. What will really matter in the long run? That’s the question we tackle each ...